Breeze Meds Review: Three NAD+ Prices on One Page

The one-sentence version

Breeze Meds has quietly become a longevity provider — NAD+ by injection and by nasal spray, plus sermorelin, on top of the compounded GLP-1 line it started with — and it bundles more into the monthly figure than most rows here: the medical consultation, unlimited consultations afterwards, secure messaging and 24/7 support, all stated as included. Then the page that sells NAD+ carries three different prices for it, its sermorelin card disagrees with its own catalogue by $35, and the site publishes no terms of service, no refund policy and no cancellation policy at all. It grades B, 9 points out of 14, computed from published terms alone and blind to who pays us — Breeze Meds is a paid partner here.

What it is, and what it sells

The operating entity is Breezemeds, LLC, described in its own inline privacy policy as "a Delaware corporation" at 134 South Avenue SE, Marietta GA 30060 — although the consultation footer says Breezemeds, Inc. The platform underneath is CareValidate, the same white-label backend behind Care Bare Rx, Synergy Rx and several others, which means its clinicians, pharmacies and FAQ language are shared property rather than independent corroboration of anyone else's.

The catalogue is short and current:

Beside it: compounded semaglutide injection at $199 a month, tirzepatide injection at $299, oral semaglutide at $299 and oral tirzepatide at $399. No glutathione, no B-12, no methylene blue, no other growth-hormone peptides, no TRT or HRT, no supplements.

Four numbers, one product, one page

Here is what /nad-plus says about NAD+, in the order you meet it:

• •the hero: *"Just $179 to start"*
• •a product card: *"Starting at $169 — NAD+ Injection"*
• •another card: *"Starting at $210 — NAD+ Nasal Spray"*
• •and the FAQ, at the bottom of the same page: *"BreezeMeds NAD+ therapy starts regular at just $249/month, including your medical consultation, prescription, medication, and free shipping."*

Three of those are for the injection. $179, $169 and $249. The card and the machine-readable catalogue the page renders from both say $169, which is why $169 is the figure this review publishes — but Breeze's own FAQ calls $249 the regular monthly rate, which is precisely the number a buyer needs and precisely the one that contradicts the card.

The sermorelin line does the same thing on a smaller scale: the card says $100, the catalogue behind the same page says $135.

Why that zeroes the price factor. Our rubric asks for a figure — singular — that a buyer can rely on before committing. Two of four numbers agreeing is not that. This is not the familiar trap where an advertised rate turns out to be a twelve-month prepay; there is no term hiding behind any of these figures. It is simpler and stranger: the page has not been reconciled with itself. Compare System Labs, which also prints two numbers per product — but prints them as a struck-through pair, first month against standing rate, so the relationship between them is legible. It keeps all four points. Breeze prints three numbers with no relationship stated at all.

And the bundles are worse than monthly. The three-month semaglutide bundle is $748, which is $249.33 a month against $199 month-to-month. Do not read the multi-month rungs as savings.

One charge that is not in any headline: an $80 consultation fee if you choose a phone or video visit and then do not proceed.

What it does publish, and it is more than you would expect

The monthly figure genuinely includes the consultation. Breeze's own FAQ says so — "including your medical consultation, prescription, medication, and free shipping" — and /nad-plus goes further: "Unlimited 24/7 Support, Included. BreezeMeds connects you with our dedicated team of NAD+ specialists… With unlimited consultations, secure messaging, and expert guidance." That is a statement about what the price buys, which is what our oversight and support factors ask for, and Breeze takes all four of those points.

Four dispensing pharmacies are named with phone numbers on its homepage — Belmar Pharmacy, Strive Pharmacy, Epiq Scripts and Casa Pharma Rx — alongside the clinical group Lion MD and two prescribing physicians with NPI numbers, Dr. Ana Lisa Carr, MD (1689841744) and Dr. Kelly Tenbrink, MD (1346482684). What it never does is classify any of them: the strings "503A" and "503B" appear nowhere on the site, so Breeze takes the middle rung of our pharmacy ladder — one point of two — for naming without classifying.

Belmar, in proportion. One of the four, Belmar, received an FDA warning letter issued 31 March 2023, addressed to "Belmar Pharma Solutions, Drug Depot, LLC., dba APS Pharmacy", and FDA closed it out on 30 October 2023. We do not restate what it alleged; the searchable index is cited below¹ and it is FDA's document to characterise. The letter is closed out, and any page that leaves that off is publishing a false impression. Breeze Meds itself holds no FDA warning letter — a live index search for "breezemeds", "breeze meds" and "Breezemeds, LLC" returned no company match, in a pass where a known-lettered company came back positive, so the clean result is real rather than a broken query. And note the direction of the trade: you can only weigh Belmar at all because Breeze names its pharmacies, which most of this board declines to do.

States: its FAQ says "We service all 50 states." No exclusion list is published against that anywhere on the site.

The paperwork that does not exist

This is the part that would give a careful buyer pause, and it has nothing to do with prices.

Breeze Meds publishes no terms of service. /terms, /terms-of-service, /privacy-policy, /privacy and /refund-policy all return 404. The privacy policy survives only as inline text on the homepage. There is no published refund policy and no published cancellation policy anywhere on the site — so what happens if a clinician declines you, if you cancel before the pharmacy fills, or if a shipment goes wrong is simply not written down. Every other row on this board that we have criticised for a harsh refund policy at least has one.

Its client-side configuration ships secrets in plaintext. The bundle every visitor loads carries a Klaviyo private API key and a Supabase URL and anon key. That is a hygiene problem in any web application and a more serious one for a service that collects health intake.

Its own claims disagree with each other. The homepage says "50,000+" patients; /nad-plus says "100,000+". And /nad-plus publishes efficacy figures — "9/10 patients report feeling 10 years younger" — attributed only to customer surveys, with no methodology, sample or date. Treat those as marketing, not evidence.

The evidence behind what it sells

This board grades providers, not molecules, but $169 a month is about $2,000 a year and the state of the evidence belongs in the decision.

The 2026 PRISMA-guided systematic review of NAD+ for anti-aging and wellness screened 113 studies including 33 human intervention trials. Oral precursors reliably raise blood NAD+³ — target engagement is real — but effects on functional, metabolic and vascular outcomes were "heterogeneous and often null or endpoint-specific," and clinical effectiveness for anti-aging or wellness "remains inconclusive"⁴. On the two routes Breeze actually sells the review is blunter: no eligible outcomes trial has evaluated injected NAD+ for these indications, and nasal delivery has less human outcome evidence still⁴. A 2025 meta-analysis in adults averaging over 60 found NAD+ precursors did not improve muscle index, grip strength, gait speed or chair-stand time⁵; the strongest randomised result in the field moved six-minute walk distance by about 17.6 metres in peripheral artery disease — a disease endpoint, not an aging one⁶.

Sermorelin is a growth-hormone-releasing analogue, and the honest summary of GH augmentation in healthy older adults is still the 2007 Annals systematic review: small body-composition changes, no demonstrated functional benefit, more adverse events⁷. Compounded NAD+ and sermorelin are not FDA-approved, and FDA's own position is that compounded drugs are not FDA-approved and it does not verify their safety, effectiveness or quality before marketing². Set that beside the "9/10 patients report feeling 10 years younger" claim and you have the whole reason we grade the evidence separately from the provider.

Where it's weak, and who should skip it

Skip it if you need to know what month two costs, because Breeze's own page gives you three answers and its FAQ calls the highest of them the regular rate. Skip it if you want a written refund or cancellation policy, because there is not one — not a harsh one, none at all. Skip it if a service handling your health intake shipping API keys in its public bundle is a dealbreaker, which is a defensible position. And skip the multi-month bundles regardless: they cost more per month than paying monthly.

Buy it if you want two NAD+ routes with the consultation, unlimited follow-up consultations, messaging and 24/7 support genuinely inside one monthly figure, from a provider that names four pharmacies and two physicians — and you are willing to get the actual monthly number confirmed in writing before your card is charged. Ask specifically: is the ongoing rate $169 or $249?

The verdict, against the rubric

Our rubric scores five things out of fourteen: price transparency (4), a genuine longevity line (4), clinical oversight (2), pharmacy disclosure (2) and human support (2). Breeze takes the full four for its longevity line — NAD+ in two routes plus sermorelin is exactly what this board ranks — two for clinical oversight, because the consultation is stated as inside the price, two for support, on published unlimited consultations and 24/7 messaging, and one of two for pharmacy, for naming four facilities without classifying them. It takes zero for price transparency, because one page carries three prices for one product. Nine out of fourteen: a B.

The fix is smaller than the criticism sounds: reconcile one page to one number, print the sermorelin figure the catalogue actually holds, and publish a terms of service with a refund policy in it. Do that and Breeze is a thirteen-point A without changing anything about the medicine or the price. Until then the review's practical advice is the same as its criticism — get the number in writing. The full graded field is at our provider rankings, the scoring is in how we grade, and what this category costs generally is in longevity clinic cost.